triazoles has been researched along with Infections in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, T; Kamata, H; Kano, R; Miura, A; Suzuki, K | 1 |
| Adas, M; Bechman, K; Clarke, B; Galloway, J; Yates, M | 1 |
| Abid, H; Abid, MB; Wu, JF | 1 |
| Jain, A; Piplani, P | 1 |
| Bartok, B; de Vlam, K; Gao, J; Genovese, MC; Gottenberg, JE; Guo, Y; Kalunian, K; Matzkies, F; Mozaffarian, N; Sundy, JS; Takeuchi, T; Tasset, C; Walker, D | 1 |
| Alten, R; Enríquez-Sosa, F; Greenwald, M; Harrison, P; Mazur, M; Pavlova, D; Tasset, C; Taylor, PC; Van der Aa, A; Vanhoutte, F; Westhovens, R | 1 |
| Cseuz, R; Greenwald, M; Harrison, P; Kavanaugh, A; Kremer, J; Ponce, L; Reshetko, OV; Stanislavchuk, M; Tasset, C; Van der Aa, A; Vanhoutte, F | 1 |
| McCarthy, MW; Walsh, TJ | 1 |
| Arribas López, JR | 1 |
| Kolnagou, A; Kontoghiorghes, GJ; Petrikkos, G; Skiada, A | 1 |
| Masmiquel Comas, L; Nicolau Ramis, J | 1 |
| Alegre, M; Alomar, A; Dalmau, J; Gurgui, M; Pimentel, CL; Roé, E; Sanchez, F | 1 |
| Alves, SH; Argenta, JS; Cavalheiro, AS; Ferreiro, L; Pereira, DI; Santurio, JM; Spanamberg, A | 1 |
5 review(s) available for triazoles and Infections
| Article | Year |
|---|---|
The safety of JAK-1 inhibitors.
Topics: Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Diverticular Diseases; Herpes Simplex; Herpes Zoster; Heterocyclic Compounds, 3-Ring; Humans; Immunocompromised Host; Infections; Intestinal Perforation; Janus Kinase 1; Janus Kinase Inhibitors; Latent Infection; Opportunistic Infections; Pyridines; Triazoles | 2021 |
Risk for infections with selinexor in patients with relapsed/refractory multiple myeloma: a systematic review of clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Humans; Hydrazines; Infections; Multiple Myeloma; Recurrence; Triazoles | 2021 |
Exploring the Chemistry and Therapeutic Potential of Triazoles: A Comprehensive Literature Review.
Topics: Humans; Infections; Inflammation; Neoplasms; Neurodegenerative Diseases; Oxidative Stress; Seizures; Triazoles | 2019 |
Prophylactic Measures During Induction for Acute Myeloid Leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antiviral Agents; Humans; Infections; Leukemia, Myeloid, Acute; Risk Factors; Triazoles | 2017 |
[Secondary effects of treatment with maraviroc and other CCR5 antagonists. Potential impact of the CCR5 blocker].
Topics: Adult; Benzoates; CCR5 Receptor Antagonists; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Comorbidity; Cyclohexanes; Diketopiperazines; Disease Susceptibility; Drug Design; env Gene Products, Human Immunodeficiency Virus; HIV Fusion Inhibitors; HIV Infections; Homozygote; Humans; Hyperlipidemias; Incidence; Infections; Maraviroc; Membrane Fusion; Neoplasms; Piperazines; Receptors, CCR5; Sequence Deletion; Spiro Compounds; Triazoles; Virus Attachment; Virus Internalization | 2008 |
3 trial(s) available for triazoles and Infections
| Article | Year |
|---|---|
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; C-Reactive Protein; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Female; Hematologic Tests; Humans; Infections; Janus Kinase 1; Male; Middle Aged; Pyridines; Remission Induction; Severity of Illness Index; Triazoles | 2019 |
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1).
Topics: Administration, Oral; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infections; Janus Kinase 1; Male; Methotrexate; Middle Aged; Protein Kinase Inhibitors; Pyridines; Severity of Illness Index; Surveys and Questionnaires; Triazoles | 2017 |
Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2).
Topics: Administration, Oral; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemoglobins; Humans; Infections; Janus Kinase 1; Male; Methotrexate; Middle Aged; Protein Kinase Inhibitors; Pyridines; Retreatment; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Triazoles | 2017 |
5 other study(ies) available for triazoles and Infections
| Article | Year |
|---|---|
In vitro algaecid effect of itraconazole and ravuconazole on Prototheca species.
Topics: Humans; Infections; Itraconazole; Microbial Sensitivity Tests; Prototheca; Thiazoles; Triazoles | 2020 |
The role of iron and chelators on infections in iron overload and non iron loaded conditions: prospects for the design of new antimicrobial therapies.
Topics: Anti-Infective Agents; Benzoates; Deferasirox; Deferiprone; Deferoxamine; Humans; Infections; Iron; Iron Chelating Agents; Iron Overload; Pyridones; Triazoles | 2010 |
[The new antidiabetic agents in the firing line.... safety reasons or witch hunt?].
Topics: Animals; Breast Neoplasms; Calcitonin; Carcinoma, Medullary; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Disease Susceptibility; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Infections; Liraglutide; Pancreatitis; Pharmacovigilance; Pioglitazone; Pyrazines; Risk Assessment; Safety-Based Drug Withdrawals; Sitagliptin Phosphate; Species Specificity; Thiazolidinediones; Thyroid Neoplasms; Triazoles; Urinary Bladder Neoplasms | 2012 |
Treatment of protothecosis with voriconazole.
Topics: Aged; Antifungal Agents; Humans; Infections; Male; Prototheca; Pyrimidines; Triazoles; Voriconazole | 2006 |
In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.
Topics: Animals; Antifungal Agents; Brazil; Dog Diseases; Dogs; Drug Synergism; Horse Diseases; Horses; Infections; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Sheep; Sheep Diseases; Terbinafine; Triazoles; Voriconazole | 2008 |